Unbound MEDLINE

Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy. Muscle & nerve [Muscle Nerve] Journal article

 
TitleAmyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy.
Author(s)Tojo K, Sekijima Y, Machida K, Tsuchiya A, Yazaki M, Ikeda SI 
InstitutionDepartment of Neurology and Rheumatology, Shinshu University School of Medicine, 3‐1‐1 Asahi, Matsumoto 390‐8621, Japan.
SourceMuscle Nerve 2008 May 27; 37(6):796-803.
AbstractWe report an amyloidogenic transthyretin (ATTR) Val30Met homozygote showing extremely early-onset, severe familial amyloid polyneuropathy (FAP). Although homozygotes have been reported to show late-onset and mild clinical manifestations, detailed analyses of the present and previously reported families suggest that homozygotes have a slightly more severe clinical course than heterozygotes. This is the youngest reported patient with ATTR Val30Met FAP, a condition believed to be attributable to homozygosity of this mutation. The clinical severity is consistent with TTR protein instability. Muscle Nerve, 2008.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID18506713
  
Advertise on this site.